Virus News and Research

Latest Virus News and Research

Lipid-peptide nanocomplexes offer new mRNA platform

A new paper reports the methodical development of lipid-peptide nanocomplexes as a delivery vehicle for messenger ribonucleic acid molecules to the tumor cell, in vitro and in vivo.

27 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Scientists conduct meta-analysis of the impact of SARS-CoV-2 on sperm parameters

Scientists conducted a meta-analysis to study the impacts of COVID-19 on the male reproductive system.

27 Jun 2022

Scientists assess potential of monkeypox transmission at mass gatherings

In a new study, researchers assessed the potential of monkeypox transmission at mass gatherings.

27 Jun 2022

COVID-19 can cause metabolism problems by interfering with insulin signaling, study reveals

It has become abundantly clear that coronavirus disease 19 (COVID-19), despite being transmitted by breathing in the SARS-CoV-2 virus, can have harmful effects far beyond the lungs.

27 Jun 2022

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Researchers evaluated the neutralizing ability of sera from COVID-19 patients.

27 Jun 2022

Chemically modified rocaglates have a stronger effect against viral replication

Hepatitis E virus (HEV) is widespread, and so far there is no effective drug. In the search for one, the so-called rocaglates have come into focus: plant compounds that can inhibit the replication of viruses.

27 Jun 2022

Review and case study illustrates the challenges of monkeypox

A new paper published in Travel Medicine and Infectious Disease reviews the history of this disease in and outside Africa, with special reference to its clinical difficulties.

27 Jun 2022

Study investigates the virological attributes of Omicron in a Syrian hamster model

Researchers investigated the virological attributes of SARS‐CoV‐2 new variant of concern Omicron in a Syrian hamster model.

27 Jun 2022

Antigenic differences between early SARS-CoV-2 variants

Researchers used antigenic cartography to quantify and visualize antigenic differences between multiple SARS‐CoV‐2 variants.

27 Jun 2022

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown.

25 Jun 2022

Antibody profiles of internal viral proteins predict severe COVID-19 outcomes

Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins.

24 Jun 2022

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.

24 Jun 2022

Virus News and Research

Latest Virus News and Research

Lipid-peptide nanocomplexes offer new mRNA platform

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Scientists conduct meta-analysis of the impact of SARS-CoV-2 on sperm parameters

Scientists assess potential of monkeypox transmission at mass gatherings

COVID-19 can cause metabolism problems by interfering with insulin signaling, study reveals

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Chemically modified rocaglates have a stronger effect against viral replication

Review and case study illustrates the challenges of monkeypox

Study investigates the virological attributes of Omicron in a Syrian hamster model

Antigenic differences between early SARS-CoV-2 variants

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

Antibody profiles of internal viral proteins predict severe COVID-19 outcomes

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

Updated Cochrane Review: No evidence to support the use of ivermectin for treating COVID-19 infection

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Serologic testing captures missed children at risk for long Covid

Natural and hybrid immunity dynamics in South African mothers

Characterization of SARS-CoV-2 Omicron persistence and infectivity among children

Mapping the trajectory of SARS-CoV-2 evolution inside the host

Ultrathin sensor helps measure different biomarkers to perform on-body chemical analysis

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in